par Résimont, Guillaume;Dubois, Bernard Emile B.;Grosch, Stéphanie;Bovy, Christophe;Collart, Frédéric 
;Krezsinski, Jean Marie
Référence RMLG. Revue médicale de Liège, 75, S1, page (41-47)
Publication Publié, 2020-09
;Krezsinski, Jean MarieRéférence RMLG. Revue médicale de Liège, 75, S1, page (41-47)
Publication Publié, 2020-09
Article révisé par les pairs
| Résumé : | COVID-19 has been the center of global attention and concern for the last months. Patients undergoing dialysis and especially those treated at the hospital are likely to be infected, due to their mandatory presence at the hospital several times a week and due to their intrinsic fragility in regard of chronic kidney disease, often an older age, and the presence of many associated comorbidities. Thereby, patients with chonic kidney disease treated by haemodialysis have higher odds of a more severe COVID-19 infection with a high mortality rate. Prevention is thus a high priority for these patients. |
